Six different polymorphic forms and an amorphous form of the drug have been identified but only forms I and II are used in pharmaceutical formulations (13). For both polymorphs, only the dextrorotatory isomer exhibits activity on platelet aggregation whereas the levorotatory isomer is less active and poorly tolerated.